by Jordana Choucair | Dec 8, 2022 | Life Sciences
Pfizer and Moderna announced that the commercial prices of their COVID-19 vaccines will likely be between $82 and $130 per dose. The cost is approximately three to four times what the federal government has paid. The Biden administration has started to prepare for the...
by Jordana Choucair | Dec 8, 2022 | M&A
LHC Group and UnitedHealth Group disclosed to the Securities and Exchange Commission that their $5.4 billion proposed merger won’t consummate as planned by the end year. According to the filing, the agreement was extended until March 28, 2023 as the two...
by Jordana Choucair | Dec 8, 2022 | Providers
Hospitals in some non-Medicaid expansion states are pitching expansion to help solve the rural health crisis. According to state projections, expansion could generate $1 billion a year and create more than 11,000 jobs in Mississippi, $32 million in savings of over the...
by Jordana Choucair | Dec 8, 2022 | Public Health/Prevention
Centers for Disease Control and Prevention (CDC) Director Rochelle Walensky said the agency needs more COVID-19 funding and authority from Congress to improve data reporting processes from states and providers. Her call for more support from Congress comes as the...
by Jordana Choucair | Dec 8, 2022 | Public Health/Prevention
The Covax initiative, which facilitates global COVID-19 vaccine sharing, could come to an end as soon as next year, per an internal board document obtained by The Washington Post. Experts said the move may be a sign that global public health institutions view COVID-19...
Recent Comments